Please ensure Javascript is enabled for purposes of website accessibility

Prostate Cancer Metabolism and Ketogenic Diet with Thomas Seyfried, PhD-EP 100

Prostate Cancer Metabolism and Ketogenic Diet with Thomas Seyfried, PhD – EP 100

Video Overview & Chapters

00:04 Expressing gratitude to the community

  • Dr. Goo expresses gratitude for the community of over 20,000 subscribers and website members for their active participation and engagement.
  • Emphasizing the importance of disseminating information on prostate cancer and men’s health to empower individuals to take proactive control over their healthcare.

02:41 Dr. Thomas Seyfried discusses the metabolism of prostate cancer and the potential ketogenic approach.

  • Dr. Seyfried is a pioneer in researching the metabolism of cancer, particularly prostate cancer, and its management through a ketogenic perspective.
  • His work has opened up new possibilities for managing prostate cancer based on metabolic approaches, shedding light on new research from the 1940s.

07:29 Research on ketogenic diets and glycolipid biochemistry in relation to cancer and epilepsy.

  • Initial lack of interest in ketogenic diets for epilepsy treatment due to historical perception.
  • Focus on gangliosides biochemistry, brain tumors, and epilepsy genetics in research.

09:36 The discovery of the potential benefits of ketogenic diet for epilepsy

  • Thomas Seyfried’s transition from studying gangliosides to researching ketogenic diet for epilepsy
  • The pivotal role of Jim Abrams in creating interest in the ketogenic diet due to his son Charlie’s struggle with epilepsy

13:50 Drugs causing body weight loss and tumor shrinkage

  • Discovery that drug caused body weight loss in mice while continuing to eat
  • Tumor shrinkage observed in mice with food restriction, showing placebo effectiveness

15:51 Ketogenic diets impact tumor architecture by shrinking blood vessels

  • Ketogenic diets lower blood sugar and elevate ketones, affecting tumor growth
  • Lindon nebling highlighted ketogenic diet’s potential impact on tumors by lowering glucose, as per OT Warberg’s theory

19:30 Abnormalities in cardiolipin affect mitochondrial function in cancer cells.

  • Abnormalities in cardiolipin control the function of the electron transport chain.
  • Supporting evidence challenges the genetic view of cancer as a somatic disease.

21:23 Warberg’s insights on cancer metabolism clashed with prevailing genetic theories

  • Sydney Weinhouse challenged Warberg’s views by suggesting all tumors require oxygen like normal cells
  • Warberg’s emphasis on cancer as a metabolic disease was overshadowed by the genetic mutation theory

25:15 Pharmaceutical industry involvement in cancer research

  • Inviting pharmaceutical industry for accelerated Cure search
  • Focus on profit rather than curing cancer

27:06 Cancer cells rely on fermentation for energy

  • Cancer cells cannot grow without fermentation of glucose and glutamine
  • Prostate cancer cells also depend on fermentation for growth

30:27 Mitochondria play a crucial role in cell function.

  • Mitochondria are like a second organism within our cells, controlling the cell’s life cycle and energy production.
  • Cancer cells with damaged oxidative phosphorylation rely on fermenting for energy, leading to tumor growth over time.

32:31 Cancer cells rely on ancient fermentation pathways

  • Cancer cells produce lactic acid and succinic acid due to inefficient energy generation organelles
  • The organelle controlling cell cycle is lost, leading to uncontrolled cell division

35:56 Cancer cells rely on glucose and glutamine for energy.

  • The mitochondria in cancer cells lose control, leading to a shift to ancient fermentation pathways.
  • Cancer cells remain locked in fermentation process due to dysfunctional organelles.

37:45 Prostate cancer cells have unique metabolic characteristics.

  • Prostate cancer cells ferment lactic acid and succinic acid.
  • They require glucose and glutamine to grow in culture.

41:14 Genetic mutations in prostate cancer are not 100% penetrant

  • Germline mutations are risk factors passed on by parents, but not every person with the mutation will develop the condition
  • Mutations in braa genes and others are 45–60% penetrant, leading to mitochondrial defects in those who develop the tumor

43:08 Mitochondrial function plays a crucial role in preventing cancer development

  • Epigenetic factors can influence mitochondrial health and impact cancer risk
  • Dysfunctional mitochondria can lead to upregulation of glucose and glutamine pathways, contributing to somatic mutations in the nucleus

46:35 Metabolic therapy for prostate cancer and its success in reducing tumor

  • Metabolic signatures in bloodstream are crucial for clinicians to examine
  • Metastatic prostate cancer in bones and outside the gland has less probability of doing well but cells can be targeted and knocked out

48:27 Prostate cancer and ketogenic diet connections

  • Discussion on the metabolic management of prostate cancer with low carbohydrate intake
  • Importance of considering glutamine levels in diet for better results

52:12 Utilizing pulsing technique for targeting tumor cells with glutamine

  • By strategically pulsing small doses of glutamine while maintaining low glucose levels, tumor cells become sensitive to targeting and can be effectively destroyed.
  • Allowing the immune system and body to recover between pulses ensures a more successful management of cancer with minimal side effects.

54:05 Personalized approach required for ketogenic diet in prostate cancer

  • Individual responses to diet challenges vary based on biochemistry and physiological condition
  • Use of glucose-ketone index to tailor doses, timing, and scheduling for each patient

57:32 Discussion on the evolutionary diet and impact on health.

  • Eating plants alone is not in line with our evolutionary existence.
  • Consideration for proper protein and glutamine intake, especially for vegans,.

59:07 Achieving a low GKI is essential for metabolic health.

  • -1.7

1:02:39 Endol acts as a glutamine inhibitor

  • Endol is a deworming drug that inhibits glutamine in cancer cells
  • Six deoxy norleucine is a stronger glutamine inhibitor used in the past for cancer management

1:04:29 Ketogenic diet as a potential therapy for cancer patients.

  • Reduce intake of glutamine and glucose, consider a low-carb diet.
  • Collaborate with a knowledgeable oncologist for individualized treatment based on GKI and imaging.

1:08:20 Ketogenic diet can change your cravings and taste perceptions.

  • Initial struggle to adjust to keto food after fasting.
  • Realization that cravings and perceptions of food change after following a ketogenic diet.

1:09:59 Maintaining low GKI through diet is key for managing prostate cancer metabolism.

  • Low GKI focuses on low glucose and high ketones, not affecting glutamine levels.
  • To manage glutamine levels, aerobic exercise and monitoring tumor growth are essential.

1:13:14 Ketogenic diet helps starve cancer cells and benefits normal cells.

  • Ketogenic diet prevents cancer cells from using glucose and ketones.
  • Water-only fasting and exercise have shown positive effects on prostate cancer.

1:14:58 Patients should have the choice between ketogenic diet and traditional treatments.

  • Medical system often pushes for physical interventions, but patients should have a say in their treatment plan.
  • Hybrid system may be needed to integrate metabolic therapy alongside traditional treatments for prostate cancer.

1:18:09 Paradigm shift in cancer management and health benefits

  • Interest in a documentary with Hollywood involvement indicates a paradigm shift in cancer management
  • Focus on managing cancer, hypertension, and diabetes by keeping mitochondria healthy

1:19:59 Sign up for Drgeo.com newsletter for actionable takeaways

  • Dr. Geo’s newsletter provides valuable information on men’s health and integrative urology.
  • Subscribing to the newsletter can keep you updated on the latest research and findings in the field of prostate cancer and ketogenic diet.